NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . December 8th, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Adenocarcinoma - Studies from S.E. Albatran and colleagues reveal new findings on adenocarcinoma

Cancer - Researchers from McGill University describe findings in cancer

Cancer - Study results from Stanford University update understanding of cancer

Cancer Vaccines - Studies from W.J. Urba and co-authors have provided new information about cancer vaccines

Chemotherapy - New findings reported from University of Athens describe advances in chemotherapy

Colon Cancer - New colon cancer study findings recently were reported by M. Tahara and co-researchers

Colon Cancer - Study results from A. Santoro et al provide new insights into colon cancer

Diabetes - Research from A.R. Bhavsar and co-authors reveals new findings on diabetes

Head and Neck Cancer - New head and neck cancer study results reported from A. Delatorre et al

Life Sciences - Data on life sciences reported by researchers at University of Paris

Life Sciences - Studies from University of California provide new data on life sciences

Myeloma - New myeloma study findings reported from T.C.M. Morris and co-authors

Myeloma - Studies in the area of myeloma reported from S. Jagannath and co-researchers

Non-Hodgkin Lymphoma - New data from University of Texas illuminate research in non-hodgkin lymphoma

Non-Small Cell Lung Cancer - Reports outline non-small cell lung cancer research from N. Ebi and colleagues

Non-Small Cell Lung Cancer - Research from Massachusetts General Hospital in the area of non-small cell lung cancer published

Non-Small Cell Lung Cancer - Research from Wake Forest University in non-small cell lung cancer provides new insights

Non-Small Cell Lung Cancer - Researchers from Ohio State University describe findings in non-small cell lung cancer

Ovarian Cancer - New ovarian cancer findings from B.O. Gonzalez and co-researchers published

Ovarian Cancer - Reports from N. Katsumata et al highlight recent research in ovarian cancer

Pharmacodynamics - Study results from J.S. Debono et al provide new insights into pharmacodynamics

Prostate Cancer - Data on prostate cancer published by O. Caffo and colleagues

Prostate Cancer - Findings in prostate cancer reported from M. Gittelman and co-researchers

Subarachnoid Hemorrhage - Recent findings from University of Toronto highlight research in subarachnoid hemorrhage

Thromboembolism - Studies in the area of thromboembolism reported from V. Paramanathan and co-researchers

Transient Ischemic Attack - Study results from Chicago Medical Center update understanding of transient ischemic attack

Tuberculosis - Studies from St. Louis University yield new information about tuberculosis

Cancer Gene Therapy - Researchers from Charite University, Max Delbruck Center for Molecular Medicine discuss findings in cancer gene therapy

Cancer Therapy - Reports from University of Texas, M. D. Anderson Cancer Center describe recent advances in cancer therapy

Cancer Vaccines - Data on cancer vaccines published by researchers at Methodist Hospital

Clinical Trial Research - Research reports from University of Heidelberg, Department of Radiation Oncology provide new insights into clinical trial research

Lung Cancer Therapy - Investigators at Democritus University release new data on lung cancer therapy

Mantle Cell Lymphoma Therapy - Research from University of Texas, M. D. Anderson Cancer Center yields new data on mantle cell lymphoma therapy

Melanoma Clinical Trial - Data on melanoma clinical trial described by researchers at Slotervaart Hospital

Non-Hodgkin Lymphoma Therapy - Study results from New York Presbyterian Hospital provide new insights into non-hodgkin lymphoma therapy

Ovarian Cancer Therapy - Researchers from University of Southern California, Norris Comprehensive Cancer Center report recent findings in ovarian cancer therapy

Squamous Cell Carcinoma Therapy - New squamous cell carcinoma therapy data have been reported by investigators at National Institute for Cancer Research, Department of Medical Oncology

Adverse Drug Reactions - Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results

Angiogenesis - CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease

ARYx Therapeutics, Inc. - ARYx Therapeutics Presents Clinical Data for ATI-5923 at American Heart Association Scientific Sessions 2008

Biopharmaceuticals - Johnson & Johnson Announces Definitive Agreement to Acquire Omrix

Cancer - Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer

Clinical Trial Research - Aegera Therapeutics' phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting

Clinical Trial Research - Strong Start to Sales of Karolinska Development's New Share Issue

Coagulation - Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483

Dyslipidemias - Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia

Hepatocellular Cancer - Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma

HIV/AIDS - EpiVax Receives NIH Grant for $390,000 to Optimize HIV Vaccine Delivery

Lupus - Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication

Metabolism - Xceleron to Provide Otsuka Pharmaceutical Development & Commercialization, Inc. with META-ID Services to Obtain Critical Metabolism Information at Phase I

Myeloma - Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology

Oncology - Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin

Parkinson Disease - Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease

Sarcoma - Common Virus Helps Quality of Life for Sarcoma Patients Says Cancer Expert

Schering-Plough Corporation - Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C

Schering-Plough Corporation - Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease

Schizophrenia - Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals

Small Cell Lung Cancer - Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin

Urinary Tract Infection - Patient Enrollment Begins in Exploratory Phase II Trial of NovaBay's Lead Aganocide Compound, NVC-422, in Catheter-Associated Urinary Tract Infections



Return to Top of Page

-----------------------
PR Login